Extended interval BNT162b2 vaccination enhances peak antibody generation. (2022)

First Author: Parry H
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41541-022-00432-w

PubMed Identifier: 35087066

Publication URI: http://europepmc.org/abstract/MED/35087066

Type: Journal Article/Review

Volume: 7

Parent Publication: NPJ vaccines

Issue: 1

ISSN: 2059-0105